Polecompetitivite

DGCIS_CMJN_bleu

Ubifrance-logo
France-logo

Request Meetings with US Companies in San Diego

Profiles of attending companies are listed below. PLEASE CHECK THIS WEBSITE REGULARLY FOR AN UPDATED LIST.

The DEADLINE to submit your meeting requests is OCTOBER, 5th.

THE PROCESS:

  1. You will receive a confirmation email for each request made
  2. UBIFRANCE will begin processing all meeting requests from October, 5th, 2012, and will confirm mutual interest from the other party
  3. A provisional schedule will be sent to you a few days before the event and a finalized schedule on the day of the event

If you have any questions about this process, please CONTACT US.

In order to improve your chances of meeting with the companies of your choice, make your meeting requests as specific, simple and direct as possible. Include information about what your company can offer and what your company is looking for.




Thumb_1348013868_abbio-gradients-jpg

ABBIOTEC

visit website request a meeting with this company
Production of antibodies and peptides for R&D and diagnostic applications with the Made in USA quality.
More ?
COMPANY :
As researchers are focusing their efforts on determining the biological functions, interactions and regulation of the human proteome, Abbiotec is dedicated to developing cell biology-based research tools that assist scientific discoveries. Besides custom services, Abbiotec offers over 12,000 antibodies, proteins, peptides, lysates and kits to assist researchers in understanding human biology and diseases at the cellular and molecular levels.
TECHNOLOGY :
Peptide synthesis using F-moc chemistry, dye and quencher conjugation. Polyclonal antibody production using the NIH 90-day immunisation protocol.
OBJECTIVES :
Supply agreement for services and/or products.
COMPANY INFORMATION :

Close
Thumb_def173a44d72feb3c1ccd6dca8349bdf

ACEA Biosciences

visit website request a meeting with this company
ACEA Biosciences, Inc. is a pioneer in the development and commercialization of high-performance microelectronic systems for real-time, label-free cell-based assays.
More ?
COMPANY :
ACEA Biosciences, Inc. (ACEA) is a private biotechnology company that is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has developed a proprietary real-time, label-free cell-based assay technology and launched its first product in 2004. Today, the company has a product line of 6 instruments which utilize this technology with different functionalities and throughputs, and which enable different types of cellular-based assay applications. The systems are commercialized globally under the xCELLigence® brand and are sold by Roche Applied Science via a strategic partnership. There are over 800 customers worldwide and over 350 peer-reviewed publications referencing the xCELLigence technology. Although our systems are versatile and are used for multiple types of applications, our customers mainly use them for the following purposes: basic science research, drug discovery and development, oncology research and toxicology screening. In addition to selling innovative instruments, ACEA collaborates with institutional clients (pharma, biotech, government agencies…etc) by providing R&D and screening services utilizing the xCELLigence technology. ACEA was founded in 2002, is headquartered in San Diego, CA and has world-class manufacturing operations in Hangzhou, China. With its international reach, ACEA continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries. For more information, please visit our website at www.aceabio.com.
TECHNOLOGY :
impedence based technology The impedance measurement provides quantitative information about the biological status of the cells, including cell number, viability, and morphology. A wide range of cell-based assays for both high throughput screening and research laboratory environments can be performed on the System. Pipeline: 1 cpd in Phase 2 clinical trial_NSCLC 3 cpds in late stage preclinical studies
OBJECTIVES :
Seeking Pharma/biotech interested in in vitro cardio safety test, and co-developement oncology drugs.
COMPANY INFORMATION :

Close
Thumb_9206f165cba1a686039a45ee19d55100

Althea Dx

visit website request a meeting with this company
companion diagnostics
More ?
COMPANY :
AltheaDx provides a start-to-finish suite of services focused on molecular biomarker discovery, assay development, assay validation and prospective/retrospective clinical trial testing in support of companion diagnostic development and commercialization. At the core of our services is a comprehensive set of gene expression and genotyping analysis capabilities for both pre-clinical and clinical applications utilizing state of the art genomics tools including real-time PCR, microarray technologies and next-generation sequencing. All of our services can be run under non-GLP, full GLP compliance and CLIA. AltheaDx provides a start-to-finish suite of services focused on molecular biomarker discovery, assay development, assay validation and prospective/retrospective clinical trial testing in support of companion diagnostic development and commercialization. At the core of our services is a comprehensive set of gene expression and genotyping analysis capabilities for both pre-clinical and clinical applications utilizing state of the art genomics tools including real-time PCR, microarray technologies and next-generation sequencing. All of our services can be run under non-GLP, full GLP compliance and CLIA.
OBJECTIVES :
networking
COMPANY INFORMATION :

Close
Thumb_9613c7b0c10de49ea717a2a264b63c73

Althea Technologies

visit website request a meeting with this company
contract development and biomanufacturing
More ?
COMPANY :
Althea Technologies is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services. Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Althea’s formulation technology platform includes Crystalomics®, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations.
TECHNOLOGY :
biologics delivery platform
OBJECTIVES :
networking
COMPANY INFORMATION :

Close
Thumb_1349116241_acc-logo170-jpg

American Custom Chemicals Corporation

visit website request a meeting with this company
American Custom Chemicals Corporation offers custom synthesis and catalog compounds and biologics for Research and Development.
More ?
COMPANY :
American Custom Chemicals Corporation specializes in making chemicals and biologics for research and development purposes only. Our online catalog features over 350,000 Compounds and biologics. We have one of the largest collections of Building Blocks and reference standards. Focus areas include a wide range of therapeutic areas including cancer, HIV, diabetes, CNS and genetic disorders.
TECHNOLOGY :
NA
OBJECTIVES :
Supplying raw materials and custom products to researchers in life sciences sector.
COMPANY INFORMATION :

Close
Thumb_1348857545_adlw-0810-jpg

Antibody Design Labs

visit website request a meeting with this company
Bridging the gap between technologies and applications in antibody generation & engineering.
More ?
COMPANY :
Antibody Design Labs is an emerging company in the field of recombinant antibodies. Our mission is to offer a point of sale for technologies and an open access to information covering multiple aspects of recombinant antibody technologies to help research laboratories and biotech companies to develop antibody generation & engineering in house. We are currently focused on developing a rich line of products for phage display.
OBJECTIVES :
Our objective is to establish contact with potential customers and better understand their specific needs.
COMPANY INFORMATION :

Close
Thumb_1349255155_2012_0907_fbb_logo-gif

French Biobeach

visit website request a meeting with this company
French BioBeach is an organization facilitating scientific business development in Life Sciences between France and San Diego
More ?
COMPANY :
French BioBeach was created in March 2006, at the initiative of the Economic Department of the French Embassy, to foster academic and business partnerships between San Diego’s entrepreneurial spirit and France’s expertise in the life sciences. French BioBeach’s board is composed of a strong network of local and international life science experts. Since 2006, French BioBeach has participated in the organization of 21 networking events in San Diego. The purpose of those events is to offer to the Franco-American Scientific community of the greater San Diego area opportunities to gather and thus create a « virtual Biotech bridge » between France & USA.
OBJECTIVES :
We are interested in meeting both French and American companies in the biotech industry to better understand how we could help them
COMPANY INFORMATION :

Close
Thumb_1349138225_liai-logo-png

La Jolla Institute for Allergy & Immunology

visit website request a meeting with this company
LIAI is focused on the immune response to infectious agents and cancers and prevention, treatment and cure of immune diseases.
More ?
COMPANY :
The La Jolla Institute for Allergy & Immunology (LIAI) is one of only a few non-profit biomedical research institutes in the world focused on understanding the immune response to infectious agents and cancers and on advancing progress toward the prevention, treatment and cure of immune system diseases. LIAI is dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand our understanding of how the immune system works and to discover the causes of immune system disorders. The knowledge gained through our biomedical research can, in turn lead to the prevention, treatment and cure of a wide range of human diseases. In furtherance of this mission, LIAI is dedicated to facilitating the advancement of scientific industry and works closely with members of our faculty to build intellectual property value from their research and transfer discoveries to the industry.
OBJECTIVES :
LIAI is interested in working with industry partners in developing our research efforts and translating our scientific discoveries into treatments for diseases and disorders of the immune system. .
COMPANY INFORMATION :

Close
Thumb_0a5866358065a90601ba45a5904293e0

Nanomol Ltd.

visit website request a meeting with this company
DMPK/Tox CRO
More ?
COMPANY :
We are specialized in DMPK/Tox service with small amount of compounds in a short turnaround time. We also provide molecular biological reagents and services.
OBJECTIVES :
We'd like to present our competitive service to drug-developing companies. We are also interested in introducing goods and services to Korea market.
COMPANY INFORMATION :

Close
Thumb_f409715d6881b9ea0b0f1ec3466094c6

Pfizer

visit website request a meeting with this company
Drug discovery and development company
More ?
COMPANY :
Drug discovery and development company
OBJECTIVES :
Outsourcing
COMPANY INFORMATION :

Close
Thumb_51da7b5f449b51a45ce1777b3b8aa24d

Pfizer / CovX

visit website request a meeting with this company
Large pharmaceutical company
More ?
COMPANY :
CovX Biotech unit within Pfizer which is focused on discovery and development of peptide-based therapeutics
OBJECTIVES :
We are interested in establishing collaborative partnerships to develop novel, differentiated peptide-based therapeutics and/or enabling technologies
COMPANY INFORMATION :

Close
Thumb_3fc7062c1b6c2c14f4e394adea9d9234

Pharmaceutical Resource Group

visit website request a meeting with this company
Quality Solutions to Technical Issues
More ?
COMPANY :
PRG offers consulting and project management services to small and emerging biotechnology companies to help guide them through the drug development process.
TECHNOLOGY :
PRG founded in 1998 offers an international consortium of experienced developmental consultants with a focus on Chemistry, Manufacturing and Controls (CMC), preclinical and clinical activities. Our team has proven success in navigating rapidly evolving companies advancing drugs to IND and through proof-of-concept clinical trial and on to NDA. By creating a setting for focusing on task(s) required for proof-of-concept PRG teams provides: Increased efficiency, lower overhead cost, depth of expertise, and team dedication. PRG will help overcome limitations in internal resources that prevent realization of objectives, and accelerate the generation of value from projects. PRG focus is on-target delivery with a Biotech and Pharmaceutical focus.
OBJECTIVES :
Collaborations with small to medium sized companies preclinical, clinical areas with a focus on immunology, inflammation and neurology.
COMPANY INFORMATION :

Close
Default_logo

Prediction Sciences

visit website request a meeting with this company
personalized medicine Dx
More ?
COMPANY :
Personalized medicine
OBJECTIVES :
clinical research, product placements
COMPANY INFORMATION :
  • Address :
      3252 Holiday Court STE 209 - 92037 La Jolla - CA
  • Website :
     http://predict.net

Close
Thumb_c57518b44ac837b4648dd2f6cfc06a9b

PRESCOS LLC

visit website request a meeting with this company
Preclinical Research and Scientific Consulting service provider
More ?
COMPANY :
PRESCOS is a fully AAALAC accredited and OLAW assured preclinical CRO that provides in vivo contract research services, as well as expert consulting services, supporting preclinical drug research and development of emerging and established pharmaceutical and biotechnology companies.
OBJECTIVES :
Looking for potential clients
COMPANY INFORMATION :

Close
Thumb_b9310885d61faefc15fe6eebb54a5860

Salk Institute for Biological Studies

visit website request a meeting with this company
The Salk Institute for Biological Studies is a global leader in life science research helping to drive new cures for patients.
More ?
COMPANY :
In 1960, just five years after developing the first safe, effective vaccine against polio, Jonas Salk, M.D. founded the institute that today bears his name. Home to 11 Nobel laureates since its founding, the Salk Institute for Biological Studies is a global leader in life science research (recently ranked in the top 5 research institutes worldwide) and is advancing our understanding of disease and helping to drive new cures for patients. With a research budget approaching $100 million per year, the Institute employs over 1100 faculty, staff and research associates, plus post-doctoral fellows and pre-doctoral students.
TECHNOLOGY :
The Institute's areas of major focus are Neurobiology, Oncology, Metabolism and Plant Science. The 60 laboratories that make up Salk are devoted to basic research in molecular, cellular, cognitive, systems and computational neurobiology; chemical biology and proteomics; infectious diseases; gene expression; gene therapy; molecular, cell, structural and regulatory biology, plant biology and genetics.
OBJECTIVES :
We seek partnerships with companies that can help to translate our discoveries into products that ultimately benefit patients.
COMPANY INFORMATION :

Close
Thumb_1348130021_tioga-logo-with-subtitle_apr11-jpg

Tioga Research, Inc.

visit website request a meeting with this company
Tioga Research strives to provide ‘best-in-class’ CRO services in the research and early development of skin-applied products, specializing in formulation innovation and skin permeation screening.
More ?
COMPANY :
Tioga Research has approaching a decade of experience in skin permeation screening, in topical formulation assessment & improvement, and in topical and transdermal formulation discovery, research & development. CRO services have been delivered successfully by Tioga Research in each of the topical/transdermal drug, prestige cosmetic, and skin-applied medical device fields.
TECHNOLOGY :
Topical drug formulations. Skin permeation screening, especially using proprietary high throughput experimentation technologies. Topical drug product concepts.
OBJECTIVES :
Networking with prospective clients, collaborators and contacts
COMPANY INFORMATION :

Close
Thumb_1348582146_darkblue-png

True Diagnostics, Inc.

visit website request a meeting with this company
Providing simple, portable and powerful answers at the point-of-care.
More ?
COMPANY :
True Diagnostics is changing medicine by providing immediate answers to the point-of-care, point-of-incidence and remote-of-care situations. Our simple, fast, portable and economical tests require only a drop of blood or small urine or saliva sample – and within minutes gives answers which allow treatment to begin immediately – and in some cases, save lives. True Diagnostics creates simple and powerful diagnostic tools for the $18 billion in vitro point-of-care markets which are fast, portable, and economical. With a small sample (a single pin prick of blood, a small urine or saliva sample, or a surface wipe), the TrueDX™ Platform conducts quantitative tests for life-threatening, quality of life and environmental conditions which provide laboratory quality results in minutes. Founded in 2010 and headed by Jerry Lee, President/CEO, True Diagnostics is a “spin-off” from Dr. James Lee (Jerry’s father), the inventor of the pregnancy test over 30 years ago and holder of 18 patents for diagnostic solutions based around lateral flow immunoassay (LFIA) technology. The Company is positioned to enter the global market quickly with: ? CE Mark for TrueDX-M.I. ™ Test (3-panel heart attack/myocardial infarction) allowing shipments to begin to Europe ? sFDA clearance and CE Mark for the TrueDX Platform with TrueDX-TSH™ Test allowing shipments to begin to China and Europe ? CE Mark is expected within a few months in Europe for T4 and PSA ? Its R&D team headed by Dr. James Lee ? Decades of experience receiving 510(k) FDA clearances and CLIA-waivers ? Over 60 tests in its product pipeline ? Certified outsourced manufacturing in the U.S. and China ? Global distribution, branding and marketing expertise The Company is closing its $10 million Series A funding for a 20% equity ownership. Use of proceeds includes expansion of development activities, conducting simple clinical tests and regulatory clearances and launch of its products into the global market. Also incorporated into this plan is a Series B round of $25 million which is expected to be filled within 12-15 months of the closing of Series A – and which gives the Company the flexibility to look at strategic biomarker acquisitions and to rapidly seed the market with more products.
TECHNOLOGY :
True Diagnostics technology is centered in the area of immunoassay diagnostics where it offers a variety of immune-chromatographic diagnostic devices designed to detect numerous health and environmental conditions (such as bacteria). The Company’s three decades of R&D history has been in one-step qualitative (yes/no results) sandwich dye conjugate immune-chromatographic assay, where unique combinations of monoclonal and polyclonal antibodies selectively identify the health condition being analyzed with a very high degree of sensitivity. With the TrueDX™ Platform, True Diagnostics has taken LFIA (Lateral Flow Immunoassay) qualitative (yes/no) technology to the next level by providing simple and portable diagnostic tests which give quantitative (degree of severity) results. This allows point-of-care personnel to gain access to laboratory quality results in minutes – not days, weeks or hours.
OBJECTIVES :
True Diagnostics looks to find partners to work with in discovery/development or new diagnostics tests and/or distribution. Additionally, the Company is seeking to close its Series A funding.
COMPANY INFORMATION :

Close
Thumb_1349116707_slide1-jpg

Visionary Pharmaceuticals

visit website request a meeting with this company
Visionary develops first-in-class small molecule immunomodulators.
More ?
COMPANY :
Visionary Pharmaceuticals is a San Diego, California based pharmaceutical company developing medicines to combat the underlying causes of many clinically important autoimmune diseases, including rheumatoid arthritis (“RA”), multiple sclerosis (“MS”), psoriasis, inflammatory bowel disease, asthma, COPD and others. Visionary has created an innovative drug discovery engine utilizing novel proprietary technology to focus on nuclear hormone receptors. Visionary Pharmaceuticals small molecule immunomodulator pipeline consists of pan-selectin antagonists (SylexinsTM) for steroid-resistant asthma/COPD and RORgamma antagonists for autoimmune disease and an orphan liver disease. The company has assembled a veteran leadership team with proven expertise in driving novel medicines to the clinic. Additionally, the Board of Directors and Scientific Advisory Board have significant industry experience in delivering high-value exits. The founders are responsible for progressing 12 compounds into late stage clinical trials, or onto the market (e.g. Revlimid® and Xalkori®), and have numerous publications/patents in their respective technical fields.
OBJECTIVES :
We seek to out-license our programs pre-clinically.
COMPANY INFORMATION :

Close